AbbVie (ABBV) Increases Buyback by $5B

The board of directors of AbbVie Inc. (NYSE: ABBV) has authorized a $5 billion increase to AbbVie's existing stock repurchase program.

Purchases may be made from time to time in management's discretion. The stock repurchase authorization permits shares to be repurchased in open market or private transactions, has no time limit and may be discontinued at any time.

You May Also Be Interested In

• Wolfe Research Upgrades Abbvie (ABBV) to Outperform
• Cycurion board approves $500,000 share repurchase program
• Apple revises EU app distribution terms, cuts fees and expands access